Accordingly, DGKζ inhibition synergizes with checkpoint inhibitors in restoring tumor‐infiltrating lymphocytes activity toward cancer cells, similarly to what observed with DGKα and putting also this isoform at the center of intensive research for inhibitors [180, 181]. This evidence concerns the gene DGKA and cancer.